| Dabigatran Etexilate 110 mg hard capsules PA0126/386/002 |
Dabigatran etexilate mesilate |
Clonmel Healthcare Ltd |
Marketed |
| Dabigatran Etexilate 150 mg hard capsules PA0126/386/003 |
Dabigatran etexilate mesilate |
Clonmel Healthcare Ltd |
Marketed |
| Dabigatran Etexilate 75 mg hard capsules PA0126/386/001 |
Dabigatran etexilate mesilate |
Clonmel Healthcare Ltd |
Not marketed |
| Dabigatran etexilate Accord 110 mg hard capsules EU/1/22/1665/007-016 |
Dabigatran etexilate mesilate |
Accord Healthcare S.L.U. |
— |
| Dabigatran etexilate Accord 150 mg hard capsules EU/1/22/1665/017-024 |
Dabigatran etexilate mesilate |
Accord Healthcare S.L.U. |
— |
| Dabigatran etexilate Accord 75 mg hard capsules EU/1/22/1665/001-006 |
Dabigatran etexilate mesilate |
Accord Healthcare S.L.U. |
— |
| Dabigatran etexilate Clonmel 110 mg hard capsules PA0126/340/002 |
Dabigatran etexilate mesilate |
Clonmel Healthcare Ltd |
Not marketed |
| Dabigatran etexilate Clonmel 150 mg hard capsules PA0126/340/003 |
Dabigatran etexilate mesilate |
Clonmel Healthcare Ltd |
Not marketed |
| Dabigatran etexilate Clonmel 75 mg hard capsules PA0126/340/001 |
Dabigatran etexilate mesilate |
Clonmel Healthcare Ltd |
Not marketed |
| Dabigatran etexilate Gedeon Richter 110 mg hard capsules PA1330/033/001 |
Dabigatran etexilate mesilate |
Gedeon Richter Plc |
Not marketed |
| Dabigatran etexilate Gedeon Richter 150 mg hard capsules PA1330/033/002 |
Dabigatran etexilate mesilate |
Gedeon Richter Plc |
Not marketed |
| Dabigatran Etexilate Krka 110 mg hard capsules PA1347/110/002 |
Dabigatran etexilate mesilate |
KRKA, d.d., Novo mesto |
Marketed |
| Dabigatran Etexilate Krka 150 mg hard capsules PA1347/110/003 |
Dabigatran etexilate mesilate |
KRKA, d.d., Novo mesto |
Marketed |
| Dabigatran Etexilate Krka 75 mg hard capsules PA1347/110/001 |
Dabigatran etexilate mesilate |
KRKA, d.d., Novo mesto |
Not marketed |
| Dabigatran etexilate Rowa 110 mg hard capsules PA0074/095/001 |
Dabigatran etexilate mesilate |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Dabigatran etexilate Rowa 150 mg hard capsules PA0074/095/002 |
Dabigatran etexilate mesilate |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Dabigatran etexilate Teva 110 mg hard capsules EU/1/23/1769/007-015 |
Dabigatran etexilate mesilate |
TEVA GmbH |
— |
| Dabigatran etexilate Teva 150 mg hard capsules EU/1/23/1769/016-023 |
Dabigatran etexilate mesilate |
TEVA GmbH |
— |
| Dabigatran etexilate Teva 75 mg hard capsules EU/1/23/1769/001-006 |
Dabigatran etexilate mesilate |
TEVA GmbH |
— |
| Dacarbazine Lipomed 1000 mg powder for solution for infusion PA1760/001/003 |
Dacarbazine |
Lipomed GmbH |
Marketed |
| Dacarbazine Lipomed 200 mg powder for solution for injection or infusion PA1760/001/001 |
Dacarbazine |
Lipomed GmbH |
Marketed |
| Dacarbazine Lipomed 500 mg powder for solution for infusion PA1760/001/002 |
Dacarbazine |
Lipomed GmbH |
Marketed |
| Dacarbazine medac 1000 mg, powder for solution for infusion PA0623/003/004 |
Dacarbazine |
medac Gesellschaft für klinische Spezialpräparate mbH |
Marketed |
| Dacarbazine medac 200 mg, powder for solution for injection/infusion PA0623/003/002 |
Dacarbazine |
medac Gesellschaft für klinische Spezialpräparate mbH |
Marketed |
| Dacarbazine medac 500 mg, powder for solution for infusion PA0623/003/003 |
Dacarbazine |
medac Gesellschaft für klinische Spezialpräparate mbH |
Marketed |
| Dacepton 10 mg/ml solution for injection in cartridge PA1774/001/003 |
Apomorphine hydrochloride hemihydrate |
EVER Valinject GmbH |
Not marketed |
| Dacepton 5 mg/ml solution for infusion PA1774/001/002 |
Apomorphine hydrochloride hemihydrate |
EVER Valinject GmbH |
Not marketed |
| Dacogen 50 mg powder for concentrate for solution for infusion EU/1/12/792/001 |
Decitabine |
Janssen-Cilag International NV |
— |
| Dafiro 10 mg/160 mg film-coated tablets EU/1/06/371/017-024 |
Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Dafiro 5 mg/160 mg film-coated tablets EU/1/06/371/009-016 |
Amlodipine besilate, Valsartan |
Novartis Europharm Limited |
— |
| Dafiro 5 mg/80 mg film-coated tablets EU/1/06/371/001-008 |
Amlodipine besilate, Valsartan |
Novartis Europharm Limited |
— |
| Dafiro HCT 10 mg/160 mg/12.5 mg film-coated tablets EU/1/09/574/13-24 |
Hydrochlorothiazide, Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Dafiro HCT 10 mg/160 mg/25 mg film-coated tablets EU/1/09/574/37-48 |
Hydrochlorothiazide, Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Dafiro HCT 10 mg/320 mg/25 mg film-coated tablets EU/1/09/574/49-60 |
Valsartan, Hydrochlorothiazide, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Dafiro HCT 5 mg/160 mg/12.5 mg film-coated tablets EU/1/09/574/1-12 |
Amlodipine besilate, Hydrochlorothiazide, Valsartan |
Novartis Europharm Limited |
— |
| Dafiro HCT 5 mg/160 mg/25 mg film-coated tablets EU/1/09/574/25-36 |
Amlodipine besilate, Hydrochlorothiazide, Valsartan |
Novartis Europharm Limited |
— |
| Daktarin 2% w/w Cream PA23490/028/001 |
Miconazole nitrate |
JNTL Consumer Health I (Ireland) Limited |
Marketed |
| Daktarin 2% w/w Cutaneous Powder PA23490/028/002 |
Miconazole nitrate |
JNTL Consumer Health (Ireland) Limited |
Marketed |
| Daktarin 20 mg/g Oral Gel PA23490/028/003 |
Miconazole |
JNTL Consumer Health I (Ireland) Limited |
Marketed |
| Dalacin 100 mg Vaginal Ovule PA0822/119/001 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Not marketed |
| Dalacin 2% vaginal cream PA0822/119/002 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Dalacin 2% Vaginal Cream PPA0465/416/001 |
Clindamycin |
PCO Manufacturing Ltd. |
— |
| Dalacin C 150 mg Hard Capsules PA0822/120/001 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Dalacin C 150 mg Hard Capsules PPA0465/205/001 |
Clindamycin |
PCO Manufacturing Ltd. |
— |
| Dalacin C 150 mg Hard Capsules PPA1463/150/001 |
Clindamycin |
IMED Healthcare Ltd., |
— |
| Dalacin C 150 mg Hard Capsules PPA23080/008/001 |
Clindamycin |
Merit Pharmaceuticals Limited |
— |
| Dalacin C Phosphate 150 mg/ml Concentrate for Solution for injection/infusion, 2ml PA0822/120/002 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Dalacin C Phosphate 150 mg/ml Concentrate for Solution for injection/infusion, 4ml PA0822/120/003 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Dalacin T Topical Lotion 10 mg/ml Cutaneous Emulsion PA0822/121/001 |
Clindamycin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Dalmane 15 mg Hard Capsules PA23355/025/001 |
Flurazepam |
Viatris Healthcare Limited |
Marketed |